Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

pharmiweb.com today archive

2334 PWToday Stories

AgaMatrix and Glytec Announce Partnership to Deliver a Cloud-Based Diabetes Management Platform to Improve Clinical Insights and Patient Blood Glucose Control

09 Jun 17

AgaMatrix, Inc. and Glytec announced today they are partnering to optimize clinical access to accurate glucose data and insulin titration support through a cloud-based diabetes management platform.

AgaMatrix is integrating their FDA-cleared Jazz Wireless 2 Bluetooth® Blood Glucose Monitoring System with Glytec's eGlycemic Management System® (eGMS®), featuring FDA-cleared Glucommander™ for evidence-based insulin dosing decision support. By automatically transferring patient blood glucose data from the AgaMatrix Diabetes Manager App to eGMS®, health care professionals are able to deliver personalized diabetes therapy management in a virtual setting. The two companies are actively engaged in a pilot of this integrated solution.

"We have a legacy of developing unique monitoring solutions that leverage a connected platform to empower more people with diabetes to easily track and share their glucose data," said John Alberico, President and CEO of AgaMatrix. "The collaboration with Glytec further emphasizes our commitment to providing better technology to enable better diabetes therapy."

Bob Leonard, President and CEO of Glytec adds: "Currently, some fifty percent of all patients on insulin are not only above their target A1C goal, they're also experiencing far too many avoidable episodes of hypoglycemia. Not surprisingly, the difficulties and costs associated with managing diabetes create major issues with medication adherence and discontinuation. Given the highly individualized complexities of basal and bolus insulin management, and the lack of dynamic tools available historically, there's no reason anyone should have expected different results. The integrated AgaMatrix-Glytec solution provides clinicians easy-to-use, highly scalable, evidence-based decision support to more effectively and efficiently titrate patients in a virtual care fashion as opposed to waiting months between office visits to make insulin dosing adjustments. We're excited to add AgaMatrix as a partner."

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.